PDX1 and type 2 diabetes mellitus: m6A methylation controls the insulin IGF1-AKT-PDX1 pathway and T2DM is exacerbated by targeting METTL3 or METTL14 to reduce m6A levels and decrease AKT phosphorylation and PDX1 protein levels (De Jesus et al., 2019).